Bench-to-Bedside Development of IMNN-001: A Non-Viral IL-12 Gene Therapy for Advanced Ovarian Cancer.
- DOI
- 10.3390/pharmaceutics18101250
- Published
- 2026 Oct 1
- Container
- Pharmaceutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics18101250,
title = {Bench-to-Bedside Development of IMNN-001: A Non-Viral IL-12 Gene Therapy for Advanced Ovarian Cancer.},
author = {Anwer K and Sood S and Sparks J and Faller DV and Limon A and Lindborg SR},
year = {2026},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics18101250},
url = {https://doi.org/10.3390/pharmaceutics18101250}
}RIS
TY - JOUR TI - Bench-to-Bedside Development of IMNN-001: A Non-Viral IL-12 Gene Therapy for Advanced Ovarian Cancer. AU - Anwer K AU - Sood S AU - Sparks J AU - Faller DV AU - Limon A AU - Lindborg SR PY - 2026 JO - Pharmaceutics DO - 10.3390/pharmaceutics18101250 UR - https://doi.org/10.3390/pharmaceutics18101250 ER -
APA
K, A., S, S., J, S., DV, F., A, L., & SR, L. (2026). Bench-to-Bedside Development of IMNN-001: A Non-Viral IL-12 Gene Therapy for Advanced Ovarian Cancer.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18101250
Source records
- pubmed · retrieved 2026-11-10T14:06:10.975Z